CA
ALT icon

Cornerstone Advisory’s Altimmune ALT Stock Holding History

Cornerstone Advisory’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32
Closed – – 236
2021
Q4 		$0 Buy
+32
New +$340 ﹤0.01% 796

Other funds holding ALT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cornerstone Advisory's ALT Position: Q1 2022 in Review

Cornerstone Advisory sold out of Altimmune (ALT) in Q1 2022, closing a stake of 32 shares.

Cornerstone Advisory first reported a position in ALT in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 103 funds tracked by Wall St. Rank hold ALT as of Q1 2022.

  • Cornerstone Advisory reported no remaining Altimmune position as of Q1 2022 after selling out during the quarter.
  • Cornerstone Advisory sold 32 Altimmune shares in Q1 2022.
  • Cornerstone Advisory first reported a position in Altimmune in Q4 2021 and held it in 1 quarter.
  • Cornerstone Advisory's Altimmune position peaked at $0 in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Altimmune as of Q1 2022.

Based on Cornerstone Advisory's 13F filing for Q1 2022, filed 20 May 2022.